Fidelio/Figaro
Purpose: to investigate the effectiveness and safety of finerenone, a blood pressure medicine, in patients with type 2 diabetes and diabetic kidney disease
Inclusion
- Men or women diagnosed with Type 2 Diabetes
- Must be at least 18 years old
- Diagnosed with diabetic kidney disease
- Stable treatment of blood pressure with ACE-inhibitors (Enalapril, Lisinopril, Quinapril, etc.) or ARBs (Losartan, Valsartan, etc.)
Exclusion
- Severe uncontrolled hypertension
- HbA1c > 12%
- Renal transplant or scheduled within the next 12 months
- Dialysis for acute renal failure within the past 12 weeks
If interested, please contact:
Katarina Vukojicic / Jamie Diner
984-974-3008 / 984-974-3017
Katarina_vukojicic@med.unc.edu / diner@med.unc.edu
If you join Fidelio/Figaro, you will receive all medications and supplies at no cost to you.